Malignant Female Reproductive System Neoplasm

Malignant Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,464
Recruiting: 821
Ph III recruiting: 96
Growth YoY: +6%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (740)

clinicaltrialsPublishedShowing 651–700 of 957 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02005965	Low Rectal Cancer Study (MERCURY II)(MERCURY II)	unknown	—	542	Royal Marsden NHS Foundation TrustOTHER	3	Sep 18, 2018	clinicaltrials
NCT01037049	Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks	unknown	Phase 2	237	Royal Marsden NHS Foundation TrustOTHER	4	Sep 17, 2018	clinicaltrials